Tissue Array
Log In | My Account | Cart (0 items) - $0.00
US Biomax, Inc.
 

GA801

Gallbladder disease spectrum (gallbladder cancer progression) tissue array, 80 cases/80 cores
Unstained: $345.00 Add to Cart
H&E (GA801s*): $345.00 Add to Cart

Microarray Panel:Gallbladder disease spectrum (gallbladder carcinoma progression) tissue microarray, containing 8 cases of gallbladder metastatic carcinoma, 22 adenocarcinoma, 15 squamous cell carcinoma, 10 adenosquamous carcinoma, 2 carcinoma in situ, 3 polyp, 8 hyperplasia, 5 inflammation and 7 adjacent normal tissue of gallbladder, single core per case
Cores:80
Cases:80
Layout:10 cols × 8 rows
Core Diameter:1.5 mm
Thickness:5 µm
Quality Control:Anti-Actin confirmed
Applications:Routine histology procedures including ImmunoHistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found on our support page.
Notes:Unless specified, all TMA slides are not coated with extra layer of paraffin (tissue cores can be easily seen on the glass), so there is no need to bake, can be directly put into xylene for de-paraffin procedure.

*Tissue Microarray Slide Types:

  • Unstained: unstained paraffin tissue microarray slide.
  • Trial: tissue microarray trial slide. 10% - 25% of cores missing. Good for titrating antibody dilution and experiment conditions. Limited numbers are available, to 2 per item per order. Test slides (tissue arrays with catalog numbers ending with 241 or 242) are recommended as a substitute.
  • H & E: Hematoxylin and Eosin stained tissue microarray slide.

Microarray Panel Display

 
Slide Label: US Biomax, Inc. Tissue Array
12345678910 
A Lym Lym Lym Lym Lym Lym Lym Lym Gal Gal  
B Gal Gal Gal Gal Gal Gal Gal Gal Gal Gal  
C Gal Gal Gal Gal Gal Gal Gal Gal Gal Gal  
D Gal Gal Gal Gal Gal Gal Gal Gal Gal Gal  
E Gal Gal Gal Gal Gal Gal Gal Gal Gal Gal  
F Gal Gal Gal Gal Gal Gal Gal Gal Gal Gal  
G Gal Gal Gal Gal Gal Gal Gal Gal Gal Gal  
H Gal Gal Gal Gal Gal Gal Gal Gal Gal Gal Marked point
Legend: Gal - Gallbladder, Lym - Lymph node

- Hyperplasia, - Inflammation, - Malignant tumor, - Malignant tumor, - Malignant tumor (stage 0), - Malignant tumor (stage I), - Malignant tumor (stage IV), - Malignant tumor (stage IVA), - Malignant tumor (stage IVB), - Metastasis, - NAT, - Polyp

Specification Sheet

Pos No. Sex Age Organ Pathology diagnosis Grade Stage TNM Type †
A1 1 F 50 Lymph node Metastatic adenocarcinoma 1–2 – – Metastasis
A2 2 F 72 Lymph node Metastatic adenocarcinoma (lymph node tissue) – – – Metastasis
A3 3 M 47 Lymph node Metastatic adenocarcinoma 2 – – Metastasis
A4 4 M 66 Lymph node Metastatic adenocarcinoma 2 – – Metastasis
A5 5 M 54 Lymph node Metastatic adenocarcinoma 2 – – Metastasis
A6 6 F 56 Lymph node Metastatic adenocarcinoma 2 – – Metastasis
A7 7 F 86 Lymph node Metastatic adenocarcinoma 3 – – Metastasis
A8 8 M 56 Lymph node Metastatic adenocarcinoma 3 – – Metastasis
A9 9 M 68 Gallbladder Mucinous adenocarcinoma 1 IV T3N0M0 Malignant
A10 10 M 46 Gallbladder Adenocarcinoma 1 – TxN0M0 Malignant
B1 11 M 55 Gallbladder Adenocarcinoma 1 IVA T3N2M0 Malignant
B2 12 M 78 Gallbladder Adenocarcinoma 1–2 I T1bN0M0 Malignant
B3 13 F 60 Gallbladder Adenocarcinoma 2 IVA T3N0M0 Malignant
B4 14 F 68 Gallbladder Adenocarcinoma 2 IVA T3N0M0 Malignant
B5 15 F 65 Gallbladder Adenocarcinoma 2 – TxN0M0 Malignant
B6 16 F 60 Gallbladder Adenocarcinoma 2 IVA TbN0M0 Malignant
B7 17 F 69 Gallbladder Adenocarcinoma 2 IVA T3N0M0 Malignant
B8 18 F 66 Gallbladder Adenocarcinoma 2 IVA T2N0M0 Malignant
B9 19 M 57 Gallbladder Adenocarcinoma 1 IVA T3N0M0 Malignant
B10 20 F 35 Gallbladder Adenocarcinoma 2 IVA T2N1M0 Malignant
C1 21 F 66 Gallbladder Adenocarcinoma 3 IVA T3N2M0 Malignant
C2 22 F 58 Gallbladder Adenocarcinoma 1 IVA T3N0M0 Malignant
C3 23 M 64 Gallbladder Adenocarcinoma (sparse) – IVA T3N0M0 Malignant
C4 24 M 74 Gallbladder Adenocarcinoma 2 IVA T3N0M0 Malignant
C5 25 F 66 Gallbladder Adenocarcinoma 2 IVA T3N0M0 Malignant
C6 26 F 72 Gallbladder Adenocarcinoma (fibrous tissue and blood vessel tissue) – IVA T3N0M0 Malignant
C7 27 F 65 Gallbladder Adenocarcinoma 3 IVA T3N0M0 Malignant
C8 28 F 67 Gallbladder Adenocarcinoma 3 IVA T3N0M0 Malignant
C9 29 F 42 Gallbladder Adenocarcinoma 3 IVA T3N0M0 Malignant
C10 30 F 68 Gallbladder Adenocarcinoma 3 IVA T3N0M0 Malignant
D1 31 F 70 Gallbladder Squamous cell carcinoma 1 IVA T3N1M0 Malignant
D2 32 M 64 Gallbladder Squamous cell carcinoma 1 IVA T3N0M0 Malignant
D3 33 F 58 Gallbladder Squamous cell carcinoma 2 IVA T3N0M0 Malignant
D4 34 F 65 Gallbladder Squamous cell carcinoma 2 IVB T3N0M1 Malignant
D5 35 M 61 Gallbladder Squamous cell carcinoma 2 IVA T3N0M0 Malignant
D6 36 F 47 Gallbladder Squamous cell carcinoma 1 IVA T3N0M0 Malignant
D7 37 F 55 Gallbladder Squamous cell carcinoma 2 IVA T3N0M0 Malignant
D8 38 M 72 Gallbladder Squamous cell carcinoma 1 IVA T3N0M0 Malignant
D9 39 F 64 Gallbladder Squamous cell carcinoma 1 IVA T3N0M0 Malignant
D10 40 M 46 Gallbladder Squamous cell carcinoma 2 IVA T3N0M0 Malignant
E1 41 M 60 Gallbladder Squamous cell carcinoma 1 IVA T3N0M0 Malignant
E2 42 F 69 Gallbladder Squamous cell carcinoma 1 IVB T3N0M1 Malignant
E3 43 M 70 Gallbladder Squamous cell carcinoma 2 IVA T3N0M0 Malignant
E4 44 F 42 Gallbladder Squamous cell carcinoma (fibrous tissue) – IVA T3N0M0 Malignant
E5 45 M 72 Gallbladder Squamous cell carcinoma 3 IVA T3N0M0 Malignant
E6 46 M 60 Gallbladder Adenosquamous carcinoma – IVA T3N0M0 Malignant
E7 47 F 46 Gallbladder Adenosquamous carcinoma – IVA T3N0M0 Malignant
E8 48 F 65 Gallbladder Adenosquamous carcinoma – I T1bN0M0 Malignant
E9 49 F 48 Gallbladder Adenosquamous carcinoma – IVA T3N0M0 Malignant
E10 50 M 76 Gallbladder Adenosquamous carcinoma – IVA T3N0M0 Malignant
F1 51 F 49 Gallbladder Adenosquamous carcinoma – IVA T3N0M0 Malignant
F2 52 F 53 Gallbladder Adenosquamous carcinoma – IVA T3N0M0 Malignant
F3 53 M 74 Gallbladder Adenosquamous carcinoma – I T1bN0M0 Malignant
F4 54 F 48 Gallbladder Adenosquamous carcinoma – IVA T3N0M0 Malignant
F5 55 F 65 Gallbladder Adenosquamous carcinoma – IVA T3N1M0 Malignant
F6 56 M 35 Gallbladder Cacinoma in situ (sparse) – 0 TisN0M0 Malignant
F7 57 M 80 Gallbladder Cacinoma in situ (chronic inflammation of fibrous tissue) – 0 TisN0M0 Malignant
F8 58 F 46 Gallbladder Polyp – – – Polyp
F9 59 F 35 Gallbladder Polyp – – – Polyp
F10 60 F 56 Gallbladder Polyp (fibrofatty tissue) – – – Polyp
G1 61 F 22 Gallbladder Adenomatoid hyperplasia – – – Hyperplasia
G2 62 F 56 Gallbladder Adenomatosis – – – Hyperplasia
G3 63 F 56 Gallbladder Adenomatosis – – – Hyperplasia
G4 64 F 44 Gallbladder Adenomatosis – – – Hyperplasia
G5 65 M 37 Gallbladder Adenomatoid hyperplasia – – – Hyperplasia
G6 66 F 35 Gallbladder Adenomatoid hyperplasia – – – Hyperplasia
G7 67 F 62 Gallbladder Adenomatoid hyperplasia – – – Hyperplasia
G8 68 F 55 Gallbladder Atypical hyperplasia of cholecystic epithelium – – – Hyperplasia
G9 69 F 73 Gallbladder Chronic cholecystitis – – – Inflammation
G10 70 M 50 Gallbladder Chronic cholecystitis – – – Inflammation
H1 71 F 67 Gallbladder Chronic cholecystitis – – – Inflammation
H2 72 M 64 Gallbladder Chronic cholecystitis – – – Inflammation
H3 73 M 55 Gallbladder Chronic cholecystitis – – – Inflammation
H4 74 F 58 Gallbladder Adjacent normal gallbladder tissue (sparse) – – – NAT
H5 75 F 36 Gallbladder Adjacent normal gallbladder tissue (Chronic cholecystitis) – – – NAT
H6 76 F 45 Gallbladder Adjacent normal gallbladder tissue (Chronic cholecystitis) – – – NAT
H7 77 F 79 Gallbladder Adjacent normal gallbladder tissue (Chronic cholecystitis) – – – NAT
H8 78 M 60 Gallbladder Adjacent normal gallbladder tissue – – – NAT
H9 79 F 62 Gallbladder Adjacent normal gallbladder tissue (fibrous tissue and blood vessel tissue) – – – NAT
H10 80 F 58 Gallbladder Adjacent normal gallbladder tissue – – – NAT
– – M 58 Skin Malignant melanoma (tissue marker) – Malignant

† For precise diagnosis, refer to pathology description.

**The grade 1-3 (or I-III) in Pathology Diagnosis is equivalent to well-differentiated, moderately-differentiated or poorly differentiated, respectively, under microscope.
Grade 1 or well-differentiated: Cells appear normal and are not growing rapidly.
Grade 2 or moderately-differentiated: Cells appear slightly different than normal.
Grade 3 or poorly differentiated: Cells appear abnormal and tend to grow and spread more aggressively.
Grade 4 or undifferentiated: *(for certain tumors), features are not significantly distinguishing to make it look any different from undifferentiated cancers which occur in other organs.

TNM grading:

T - Primary tumor
Tx - Primary tumor cannot be assessed
T0 - No evidence of primary tumor
Tis - Carcinoma in situ; intraepithelial or invasion of lamina propria
T1 - Tumor invades submucosa
T2 - Tumor invades muscularis propria
T3 - Tumor invades through muscularis propria into subserosa or into non-peritonealized pericolic or perirectal tissues.
T4 - Tumor directly invades other organs or structures and/or perforate visceral peritoneum

N - Regional lymph nodes
Nx - Regional lymph nodes cannot be assessed
N0 - No regional lymph node metastasis
N1 - Metastasis in 1 to 3 regional lymph nodes
N2 - Metastasis in 4 or more regional lymph nodes

M - Distant metastasis
Mx - Distant metastasis cannot be assessed
M0 - No distant metastasis
M1 - Distant metastasis

Find overlapping cases with this tissue array:
© 2003 - 2011 US Biomax Inc., custsrv@biomax.us, Tel: (800) 935-1357 | Privacy Policy

Authorize.Net Seal Starfield Seal